Market Currents
Repligen's (RGEN +5%) jumps after its spinal muscular atrophy drug gets a fast-track designation...
-
Thursday, June 23, 2011, 4:17 PM ETRepligen's (RGEN +5%) jumps after its spinal muscular atrophy drug gets a fast-track designation from the FDA, and a postive opinion for orphan status from the European Medicines Agency.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
